Download European Respiratory Society Annual Congress 2013

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Anaphylaxis wikipedia , lookup

Germ theory of disease wikipedia , lookup

Globalization and disease wikipedia , lookup

Polyclonal B cell response wikipedia , lookup

Social immunity wikipedia , lookup

Common cold wikipedia , lookup

Inflammation wikipedia , lookup

Adaptive immune system wikipedia , lookup

Cancer immunotherapy wikipedia , lookup

Immune system wikipedia , lookup

Vaccination wikipedia , lookup

DNA vaccination wikipedia , lookup

Autoimmunity wikipedia , lookup

Rheumatoid arthritis wikipedia , lookup

Ankylosing spondylitis wikipedia , lookup

Innate immune system wikipedia , lookup

Sociality and disease transmission wikipedia , lookup

Immunomics wikipedia , lookup

Neonatal infection wikipedia , lookup

Immunosuppressive drug wikipedia , lookup

Allergy wikipedia , lookup

Psychoneuroimmunology wikipedia , lookup

Hygiene hypothesis wikipedia , lookup

Transcript
European Respiratory Society
Annual Congress 2013
Abstract Number: 6037
Publication Number: PP156
Abstract Group: 1.1. Clinical Problems
Keywords: no keyword selected
Title: LSC 2013 abstract - Age of first allergen exposure is critical in determining the development of allergic
airway disease
Rebekah Sherburn 1, Sejal Saglani 1, Jessica Vasiliou 1, Stephen Lui 1 and Clare Lloyd 1. 1 NHLI, Imperial
College, London, United Kingdom .
Body: The immunological landscape of adult and neonatal lungs are different. While adult lungs are
immunologically mature and able to mount both innate and adaptive immune responses, neonatal lungs are
developing and undergoing immune maturation. Failure of development of allergic airway disease (AAD)
following inhaled house dust mite (HDM) commencing at 14 days of age in neonatal mice has been
described. However, we have documented robust AAD in neonatal mice when HDM exposure is
commenced from day 3 of life. We hypothesised that age at first allergen exposure is critical in determining
development of allergic immune responses and aimed to investigate disease progression when allergen
exposure is commenced at different ages. Intranasal HDM or saline was administered intermittently for 3
weeks, with the first dose administered from day 3, 7, 14, 21, 28 or 42 of life. Airway hyperresponsiveness
(AHR) to methacholine, inflammation in lung and broncho-alveolar lavage, cytokine mediators of AAD in the
lungs, and serum Ig E were measured. HDM exposure at day 3 or 7 of life resulted in the development of
AHR, eosinophilic inflammation and increased Th2 cytokines (IL-4 and IL-13) in the lung, with elevated
serum IgE. In contrast, allergen exposure from day 14 or 21 of life did not result in the development of AAD,
with AHR, serum IgE and Th2 cytokines remaining at control levels. The development of AAD in response
to HDM exposure was restored when allergen was administered from day 28 and 42 of life. This study
demonstrates the critical role of immune maturation and lung development in determining the development
of allergic immune responses and the development of neonatal AAD.